Showing results (1481-1490 of 1,491) with videos related to
Sort By:
Pageof 150
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
NCCN Guidelines Insights: Survivorship, Version 1.2016Crystal S Denlinger, Jennifer A Ligibel, Madhuri Are, et al.Nature|July 31, 2025
ACLY inhibition promotes tumour immunity and suppresses liver cancerJaya Gautam, Jianhan Wu, James S V Lally, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
NCCN Guidelines® Insights: Survivorship, Version 1.2022Tara Sanft, Andrew Day, Lindsay Peterson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 2, 2021
Survivorship, Version 1.2021Amye Tevaarwerk, Crystal S Denlinger, Tara Sanft, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
NCCN Guidelines® Insights: Survivorship, Version 1.2023Tara Sanft, Andrew Day, Shannon Ansbaugh, et al.JAMA Network Open|October 2, 2023
Accuracy and Reliability of Chatbot Responses to Physician QuestionsRachel S Goodman, J Randall Patrinely, Cosby A Stone, et al.Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2025
NCCN Guidelines® Insights: Survivorship, Version 2.2025Tara Sanft, Andrew T Day, Shannon M Ansbaugh, et al.Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.Gastroenterology|December 24, 2021
Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug DevelopmentTongqi Qian, Naoto Fujiwara, Bhuvaneswari Koneru, et al.Pageof 150